Arcutis Biotherapeutics, Inc.
ARQT
$22.91
$0.673.01%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/25/2025
-
MarketBeat
3/19/2026
-
Tickeron - Stocks
3/19/2026
-
Simply Wall St
3/19/2026
-
Simply Wall St
3/18/2026
-
TipRanks Financial Blog
3/18/2026
-
Globe Newswire
3/15/2026
-
MarketBeat
3/10/2026
-
Globe Newswire
3/9/2026
-
TipRanks Financial Blog
3/8/2026
-
Simply Wall St
3/6/2026
-
Insider Monkey
3/6/2026
-
Yahoo! Finance: News
3/6/2026
-
MarketBeat
3/6/2026
-
Simply Wall St
3/6/2026
-
Insider Monkey
3/5/2026
-
Globe Newswire
3/5/2026
-
Ticker Report
3/5/2026
-
TipRanks Financial Blog
3/4/2026
-
Ticker Report
3/4/2026
-
Yahoo! Finance: News
3/4/2026
-
MarketBeat
Arcutis Biotherapeutics (ARQT, $23.6) Stochastic Oscillator left the oversold zone on March 03, 2026
3/4/2026
-
Tickeron - Stocks
3/4/2026
-
MarketBeat
3/4/2026
-
MarketBeat
3/4/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
805 418 5006
Address
3027 Townsgate Road
Westlake Village, CA 91361
Westlake Village, CA 91361
Country
Year Founded
Business Description
Sector
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company’s lead product is ZORYVE, a topical...
more